DE69935782D1 - Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna - Google Patents

Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna

Info

Publication number
DE69935782D1
DE69935782D1 DE69935782T DE69935782T DE69935782D1 DE 69935782 D1 DE69935782 D1 DE 69935782D1 DE 69935782 T DE69935782 T DE 69935782T DE 69935782 T DE69935782 T DE 69935782T DE 69935782 D1 DE69935782 D1 DE 69935782D1
Authority
DE
Germany
Prior art keywords
breast cancer
bcrp
encoding dna
resistant protein
cancer resistant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69935782T
Other languages
English (en)
Other versions
DE69935782T3 (de
DE69935782T2 (de
Inventor
Douglas D Ross
L Austin Doyle
Lynne Abruzzo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland at Baltimore
Original Assignee
University of Maryland at Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22115664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69935782(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University of Maryland at Baltimore filed Critical University of Maryland at Baltimore
Application granted granted Critical
Publication of DE69935782D1 publication Critical patent/DE69935782D1/de
Publication of DE69935782T2 publication Critical patent/DE69935782T2/de
Publication of DE69935782T3 publication Critical patent/DE69935782T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69935782.9T 1998-02-05 1999-02-05 Brustkrebsresistenzprotein (BCRP) und für dieses kodierende DNA Expired - Lifetime DE69935782T3 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7376398P 1998-02-05 1998-02-05
US73763P 1998-02-05
EP99908097.1A EP1054894B2 (de) 1998-02-05 1999-02-05 Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
PCT/US1999/002577 WO1999040110A1 (en) 1998-02-05 1999-02-05 Breast cancer resistance protein (bcrp) and the dna which encodes it

Publications (3)

Publication Number Publication Date
DE69935782D1 true DE69935782D1 (de) 2007-05-24
DE69935782T2 DE69935782T2 (de) 2007-08-16
DE69935782T3 DE69935782T3 (de) 2017-01-05

Family

ID=22115664

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69935782.9T Expired - Lifetime DE69935782T3 (de) 1998-02-05 1999-02-05 Brustkrebsresistenzprotein (BCRP) und für dieses kodierende DNA

Country Status (10)

Country Link
US (4) US6313277B1 (de)
EP (1) EP1054894B2 (de)
JP (1) JP4187412B2 (de)
AT (1) ATE359291T1 (de)
AU (1) AU755567B2 (de)
CA (1) CA2319715C (de)
DE (1) DE69935782T3 (de)
ES (1) ES2284243T5 (de)
IL (4) IL137466A0 (de)
WO (1) WO1999040110A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2284243T5 (es) * 1998-02-05 2017-08-22 University Of Maryland Baltimore Proteína de resistencia de cáncer de mama (BCRP) y el ADN que la codifica
US7622557B2 (en) * 1998-05-28 2009-11-24 St. Jude Children's Research Hospital Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (BCRP)
WO1999061589A2 (en) 1998-05-28 1999-12-02 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
US7138493B1 (en) * 1998-11-30 2006-11-21 The United States Of America As Represented By The Department Of Health And Human Services ATP-binding cassette protein responsible for cytotoxin resistance
AU1924000A (en) * 1998-11-30 2000-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The An atp-binding cassette protein responsible for cytotoxin resistance
WO2000069390A2 (en) * 1999-05-17 2000-11-23 Cancer Research Ventures Limited Compositions for improving bioavailability of orally administered drugs
AU2001288061A1 (en) * 2000-10-03 2002-04-15 Banyu Pharmaceutical Co., Ltd. Drug resistance-associated gene and use thereof
HU0100947D0 (en) * 2001-03-02 2001-05-28 Solvo Kft Screening system based on expression of abcg2 half transporter protein in an expression system free of other abc-transporters, abcg2 homodimers
WO2003035685A1 (en) * 2001-10-24 2003-05-01 Solvo Biotechnology Inc. Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
US20060135445A1 (en) * 2003-02-04 2006-06-22 Kabushiki Kaisha Yakult Honsha Breast cancer-resistant protein inhibitor
JP2006069910A (ja) * 2004-08-31 2006-03-16 Yoshiichi Sugimoto 抗癌剤耐性克服剤
EP1672365A1 (de) * 2004-12-16 2006-06-21 Het Nederlands Kanker Instituut Mittel und Verfahren zur Bestimmung und Beeinflussung des zellulären Transports
US7465788B2 (en) * 2005-01-18 2008-12-16 University Of Maryland Breast cancer resistance protein (BCRP) and antibodies thereto
CN108949694B (zh) 2012-09-11 2022-06-17 康宁有限公司 瞬时过表达编码药物转运蛋白和/或药物代谢酶的基因的可消耗的低温保存的细胞
KR101561965B1 (ko) 2013-11-27 2015-10-20 한국과학기술연구원 디스코이딘 도메인 수용체 2 활성을 조절하는 물질의 동정 방법
EP3966340A4 (de) * 2019-05-08 2024-01-03 The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo Terpen-synthasen und transporter

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585479A (en) * 1992-07-24 1996-12-17 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human ELAM-I RNA
US5489519A (en) * 1992-10-27 1996-02-06 Queen's University At Kingston Multidrug resistance protein
EP0975795A1 (de) * 1997-02-24 2000-02-02 TM Technologies Inc. Verfahren zur selektion von anti-strang-oligonukleotiden
WO1998055614A2 (en) * 1997-06-04 1998-12-10 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
ES2284243T5 (es) * 1998-02-05 2017-08-22 University Of Maryland Baltimore Proteína de resistencia de cáncer de mama (BCRP) y el ADN que la codifica
JP2002534055A (ja) * 1998-05-14 2002-10-15 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物ｖ
CA2344107A1 (en) * 1998-09-25 2000-04-06 Bayer Aktiengesellschaft Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases
AU1924000A (en) * 1998-11-30 2000-07-03 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The An atp-binding cassette protein responsible for cytotoxin resistance
AU2001288061A1 (en) 2000-10-03 2002-04-15 Banyu Pharmaceutical Co., Ltd. Drug resistance-associated gene and use thereof
JP2005529618A (ja) 2002-06-17 2005-10-06 萬有製薬株式会社 Ａｂｃｇ２多型による薬物輸送能の予測方法

Also Published As

Publication number Publication date
US7541437B2 (en) 2009-06-02
ATE359291T1 (de) 2007-05-15
WO1999040110A1 (en) 1999-08-12
US7655755B2 (en) 2010-02-02
JP4187412B2 (ja) 2008-11-26
EP1054894A1 (de) 2000-11-29
AU755567B2 (en) 2002-12-12
EP1054894B2 (de) 2016-11-09
JP2002502592A (ja) 2002-01-29
EP1054894B1 (de) 2007-04-11
IL137466A0 (en) 2001-07-24
IL137466A (en) 2011-04-28
US20030036645A1 (en) 2003-02-20
ES2284243T5 (es) 2017-08-22
DE69935782T3 (de) 2017-01-05
IL191982A (en) 2011-09-27
IL191982A0 (en) 2008-12-29
AU2761099A (en) 1999-08-23
CA2319715A1 (en) 1999-08-12
EP1054894A4 (de) 2002-03-13
DE69935782T2 (de) 2007-08-16
US20050272684A1 (en) 2005-12-08
US7741445B2 (en) 2010-06-22
US6313277B1 (en) 2001-11-06
CA2319715C (en) 2012-08-07
IL177612A (en) 2011-04-28
ES2284243T3 (es) 2007-11-01
US20090104199A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
IL191982A0 (en) Breast cancer resistance protein (bcrp) and the dna which encodes it
TR199701462T1 (xx) DNA Dizisi ve bununla kodlanm�� meme'ye �zel g���s kanseri proteini.
DE60227974D1 (de) Diagnostische tests auf periostinbasis
CY1112101T1 (el) Νευροτροφικοι παραγοντες
DE69939982D1 (de) B7l-1 moleküle
ES2077666T3 (es) Proteina de union a fibronectina y su preparacion.
EE9800306A (et) Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad
IL193886A (en) Antibodies that bind to ldcam sequences
DE50012863D1 (de) Strukturprotein von adeno-assoziiertem virus mit veränderten chromatographischen eigenschaften
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
ES2085993T3 (es) Proteina asociada a la pancreatitis aguda, medios para el diagnostico de la pancreatitis aguda.
EP1090294A4 (de) Verfahren um die anwesenheit von krebs in einer probe zu bestimmen durch nachweis der expression eines ssx-gens und peptiden, die von ssx oder ny-eso-1 abgeleitet sind
ATE398630T1 (de) Zyklische conotoxin-peptide
AU3392901A (en) Proteins
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
FI971276A (fi) Lerk-6:ksi nimetty sytokiini
DE60327344D1 (de) Gpr54 'knock-out' säugetiere und screening-verfahren, die sie verwenden
DE60221501D1 (de) Bfit (brown fat inducible thioesterase) polypeptide und polynukleotide und ihre verwendung
SE9501362D0 (sv) Smalbandigt integrerat applikationsnät med multifunktionalitet
WO2002090991A3 (en) Proteins and genes for diagnosis and treatment of erbb2-related cancer
ATE408687T1 (de) Semaphorin polypeptide
ATE290394T1 (de) Verwendung von adenoassoziierten viren zur senkung der radio- oder chemotherapieinduzierten resistenz bei krebspatienten
DK0858465T3 (da) Protein med antitumorvirkning.
IL152232A0 (en) Promoter to il-18bp, its preparation and use
SE0003099D0 (sv) Adhesive protein and uses therefore

Legal Events

Date Code Title Description
8363 Opposition against the patent